Invesco Biotechnology & Genome ETF
PBE
PBE
81 hedge funds and large institutions have $80.7M invested in Invesco Biotechnology & Genome ETF in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+10
Holders Change %
+14.08%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
16
Reduced
23
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.38M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.62M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$594K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$468K |
| 5 |
CA
Calton & Associates
Tampa,
Florida
|
+$314K |
